Sobi, Inc. Leadership

Rami Levin

President, North America

Employed since January 2014. MBA - Rekanati Business School, Tel-Aviv University, Israel . BSc in Biology - Tel-Aviv University, Israel. Over 18 years of experience in the pharmaceutical industry in a variety of Marketing, Sales and General Management leadership roles in different countries.

Previous positions: Various senior positions within Merck Serono since 1998, most recently as Vice President of Marketing (US) 2012-2014. Managing Director Scandinavia (Sweden) 2008-2012. Global Marketing Head (Switzerland) 2001-2008. Business Unit Manager (Israel) 1998-2001. Product Manager, Schering AG (Israel) 1996-1998.

Linea Aspesi

Vice President, Human Resources, North America

Linea Aspesi

Employed since January 2018. More than 20 years of proven success aligning talent priorities with business strategy. Experience spanning talent acquisition, management and retention; performance management; total rewards; organizational design; and employee relations.

Previous positions: Multiple positions in human resources at Sanofi, 2008 – 2017, most recently head of human resources for the Industrial Affairs organization in the U.S. Also served as a member of the Sanofi North America HR Leadership Team, the global HR Industrial Affairs Council and the U.S. Industrial Affairs Country Council. Previously held HR positions at multiple healthcare organizations including UMass Memorial Medical Center (2005-2008) and Partners Healthcare System Inc. (2002-2005).

Christine Belin

Vice President, Finance, North America

Employed since September 2014. MBA- Johnson Graduate School of Management at Cornell University, BS in Chemical Engineering from Cornell University. Over 15 years of experience in the pharmaceutical industry in a variety of finance leadership roles.

Previous positions: Director of Finance and Revenue Accounting at Ariad Pharmaceuticals 2013-2014, Director of Commercial Financial Planning and Analysis at Human Genome Sciences 2010-2013, and various positions at Amgen from 2002 through 2010 including Director of Finance for Colorado Operations 2007-2010 and Senior Finance Manager of Europe R&D at Amgen, Ltd in Cambridge, UK 2005-2007. Before Amgen, she worked as a reservoir engineer at Shell Exploration and Production Co.

Matthew Boyd

Vice President, Head of Regulatory Affairs, North America

Employed since September 2014. MBA - Indiana University, Kelley School of Business, B.Sc. in Pharmacy - University of the Sciences, Philadelphia College of Pharmacy.

Previous positions: Various positions within Merck Serono since 2005, most recently asDirector of Digital and Social Media, Global Marketing Excellence (2012-2014). Director US Regulatory Affairs (2009-2012). Director US Regulatory Affairs, Sanofi (US) 2005-2009. Associate Director Global Promotion Compliance and Labeling, Bristol-Myers Squibb (US) 2001-2005.

Scott Brewster

Vice President, Head of Operations and Patient Access, North America

Employed since October 2009. B.A. in American Studies from Washington College. Over 25 years of experience in the pharmaceutical/biotech industry in a variety of leadership roles ranging from Sales, Reimbursement, Logistics, Government Affairs to Patient Access.

Previous positions: Various senior level positions within Start-up biotech organizations and large pharmaceutical companies throughout North America, most recently at SOBI, Inc as Director of Reimbursement and Logistics, N.A. 2009-2014. Corporate Account Director at Inspire Pharmaceuticals (US) 2007-2009. Government Account Director (US) Encysive Pharmceuticals 2005-2007. 

Heather Golding

Vice President, Head of Legal and Compliance, North America

Employed since November 2015. J.D. – University of Connecticut School of Law. B.A. –International Studies, Colby College. Over 10 years of experience providing legal and compliance guidance to the pharmaceutical industry. 

Previous positions: Director, Legal and Compliance at Takeda Oncology (formerly Millennium Pharmaceuticals) (2013-2015); Assoc. Director, Corporate Compliance at Takeda Oncology (2011-2013). Associate, Government Enforcement and Compliance Practice Group at Choate, Hall & Stewart LLP (2005-2011). Special Assistant District Attorney, Suffolk County, MA (2010). 

Holly May

Vice President, Sales and Marketing, United States

Holly May

Employed since January 2018. Proven commercial leader with 20 years’ experience in sales and marketing. Specific expertise in rare diseases, commercial strategies, commercial analytics, launch readiness and life-cycle management.

Previous positions: Multiple positions at Sanofi, 2000-2017, including vice president and head of U.S. Fabry and xLSD marketing at Sanofi Genzyme Rare Disease, vice president and head of U.S. Fabry at Genzyme Rare Disease, director of marketing operations and strategic planning of Sanofi’s Global Oncology Division, and regional sales director for Sanofi’s cardiovascular business unit. Multiple sales and marketing positions at DuPont Pharmaceuticals Co., DuPont Merck Pharmaceutical Co. and Endo LLC.

Bob McLay

General Manager, Canada

Bob McLay

Employed since February, 2016. MBA – Auburn University, Auburn Alabama. BSc – University of Guelph, Guelph, Ontario. Over 23 years of experience in the pharmaceutical industry with multiple leadership roles in marketing, sales, patient access, supply chain, trade relations and business development.

Previous Positions: Multiple senior level positions with both large and small pharmaceutical companies. Most recently, VP Sales and Marketing & Canadian Commercial Lead at Merus Labs International (2014-2015), Director of Sales at Takeda Canada (2012-2013), Marketing Director at Graceway Pharmaceuticals (2007-2012), Associate Sales Director and other various sales and marketing roles at Pfizer Canada (1994-2007).

Trista Morrison

Vice President, Head of Communications, North America

Trista Morrison

Employed since July 2017. Over 15 years’ experience in biopharmaceutical communications, including corporate narrative, media relations, social media, crisis management, internal communications, product public relations and corporate social responsibility. Named a 2017 Top Woman in PR by PR News.

Previous positions: Director of corporate communications at Ironwood Pharmaceuticals, 2012-2017. Staff Writer for BioWorld Today and Editor for BioWorld Insight, 2006-2012. Various positions with biopharmaceutical-focused public relations agency Porter Novelli Life Sciences (formerly Atkins + Associates), 2001-2006.

Len Walt

Vice President, Head of Medical Affairs, North America

Employed since March 2015, M.D - Univ. of Witwatersrand, Johannesburg MBA - Univ. of Cape Town .Over 25 years experience in the biotechnology and pharmaceutical industries in a variety of Medical Affairs roles.

Previous positions: Global Medical Director, Sobi (2015-2016), Medical Director Canada, Sobi (2015), Medical Director at Biogen Idec Canada (2006 -2015), Vice-President Research & Development at Sanofi-Synthelabo Canada (2000 - 2004) and Vice-President Research and Development at Glycodesign Inc (1999 - 2000),  Medical Director at Hoffman La Roche Canada (1996 - 1999), Medical Advisor at Glaxo Wellcome Canada (1993 - 1996) and  Medical Director at Hoechst South Africa (1991 - 1992).